UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Impact of the COVID-19 pandemic on use of anti-dementia medications in 34 European and North American countries

Ju, C; Lau, WCY; Hayes, JF; Osborn, D; Man, KKC; Chan, EW; Wong, ICK; (2021) Impact of the COVID-19 pandemic on use of anti-dementia medications in 34 European and North American countries. Alzheimer’s & Dementia: Translational Research & Clinical Intervention , 7 (1) , Article e12206. Green open access

[thumbnail of Wei_A D Transl Res   Clin Interv - 2021 - Ju - Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34.pdf]
Preview
Text
Wei_A D Transl Res Clin Interv - 2021 - Ju - Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34.pdf

Download (549kB) | Preview

Abstract

INTRODUCTION: The impact of the COVID-19 pandemic on the global use of anti-dementia medication is unknown. We aimed to determine the changes of anti-dementia medication use in Europe (EU) and North America (NA) during the pandemic. METHODS: This is a cross-sectional study using sales data of anti-dementia medications in 2019 and 2020 from 34 EU and NA countries. The monthly uses of anti-dementia medications from January through June in 2020 were compared to the corresponding months in 2019 for each country. RESULTS: In the pre-pandemic period of January to March 2020, 70 out of 102 (3 months x 34 countries) measurements (68.6%) of monthly sales volume showed an increase. In contrast, 76.5% and 85.3% countries showed reduced sales in April and May 2020, respectively. DISCUSSION: These findings indicate changes in use of anti-dementia medications during the pandemic. The delivery of pharmaceutical care for dementia patients may be heavily disrupted in certain countries.

Type: Article
Title: Impact of the COVID-19 pandemic on use of anti-dementia medications in 34 European and North American countries
Open access status: An open access version is available from UCL Discovery
Publisher version: https://doi.org/10.1002/trc2.12206
Language: English
Additional information: © 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: Anti-dementiamedications,COVID-19,dementia,globalhealth
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy
URI: https://discovery.ucl.ac.uk/id/eprint/10132214
Downloads since deposit
5Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item